These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12049679)

  • 1. Patients with persistent atrial fibrillation taking oral verapamil exhibit a lower atrial frequency on the ECG.
    Bollmann A; Sonne K; Esperer HD; Toepffer I; Klein HU
    Ann Noninvasive Electrocardiol; 2002 Apr; 7(2):92-7. PubMed ID: 12049679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG.
    Bollmann A; Sonne K; Esperer HD; Toepffer I; Langberg JJ; Klein HU
    Cardiovasc Res; 1999 Oct; 44(1):60-6. PubMed ID: 10615390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variations in atrial fibrillatory frequency in persistent human atrial fibrillation.
    Bollmann A; Sonne K; Esperer HD; Toepffer I; Klein HU
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1867-71. PubMed ID: 11139945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil.
    Meurling CJ; Ingemansson MP; Roijer A; Carlson J; Lindholm CJ; Smideberg B; Sornmo L; Stridh M; Olsson SB
    Europace; 1999 Oct; 1(4):234-41. PubMed ID: 11220560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of atrial fibrillatory activity to carotid sinus massage in patients with atrial fibrillation.
    Bollmann A; Wodarz K; Esperer HD; Toepffer I; Klein HU
    Pacing Clin Electrophysiol; 2001 Sep; 24(9 Pt 1):1363-8. PubMed ID: 11584458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genotype-dependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation genotype ECG-phenotype correlation in atrial fibrillation.
    Husser D; Stridh M; Sörnmo L; Roden DM; Darbar D; Bollmann A
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):24-8. PubMed ID: 19305639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency measures obtained from the surface electrocardiogram in atrial fibrillation research and clinical decision-making.
    Bollmann A; Husser D; Stridh M; Soernmo L; Majic M; Klein HU; Olsson SB
    J Cardiovasc Electrophysiol; 2003 Oct; 14(10 Suppl):S154-61. PubMed ID: 14760918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillatory frequency predicts atrial defibrillation threshold and early arrhythmia recurrence in patients undergoing internal cardioversion of persistent atrial fibrillation.
    Bollmann A; Mende M; Neugebauer A; Pfeiffer D
    Pacing Clin Electrophysiol; 2002 Aug; 25(8):1179-84. PubMed ID: 12358167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study: Noninvasive monitoring of oral flecainide's effects on atrial electrophysiology during persistent human atrial fibrillation using the surface electrocardiogram.
    Husser D; Binias KH; Stridh M; Sornmo L; Olsson SB; Molling J; Geller C; Klein HU; Bollmann A
    Ann Noninvasive Electrocardiol; 2005 Apr; 10(2):206-10. PubMed ID: 15842433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring.
    Niwano S; Fukaya H; Sasaki T; Hatakeyama Y; Fujiki A; Izumi T
    Europace; 2007 Dec; 9(12):1209-15. PubMed ID: 17897926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion.
    Bollmann A; Husser D; Steinert R; Stridh M; Soernmo L; Olsson SB; Polywka D; Molling J; Geller C; Klein HU
    J Cardiovasc Electrophysiol; 2003 Oct; 14(10 Suppl):S162-5. PubMed ID: 14760919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation.
    Ramanna H; Elvan A; Wittkampf FH; de Bakker JM; Hauer RN; Robles de Medina EO
    J Am Coll Cardiol; 2001 Apr; 37(5):1403-7. PubMed ID: 11300453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface ECG f Wave Analysis of Dofetilide Drug Effect in the Atrium.
    Raygor VP; Ng J; Goldberger JJ
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):644-8. PubMed ID: 25711372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
    Fetsch T; Burschel G; Breithardt G; Engberding R; Koch HP; Lukl J; Trappe HJ; Treese N
    Z Kardiol; 1999 Mar; 88(3):195-207. PubMed ID: 10355070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal-averaged P wave reflects change in atrial electrophysiological substrate afforded by verapamil following cardioversion from atrial fibrillation.
    Redfearn DP; Skanes AC; Lane J; Stafford PJ
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1089-95. PubMed ID: 17038141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation.
    Pandozi C; Bianconi L; Calò L; Castro A; Lamberti F; Scianaro MC; Gentilucci G; Santini M
    J Am Coll Cardiol; 2000 Dec; 36(7):2234-41. PubMed ID: 11127466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the atrial rate as a factor modulating ventricular response during atrial fibrillation.
    Climent AM; Guillem MS; Husser D; Castells F; Millet J; Bollmann A
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):1510-7. PubMed ID: 20636310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation.
    Hesselkilde EZ; Carstensen H; Haugaard MM; Carlson J; Pehrson S; Jespersen T; Buhl R; Platonov PG
    BMC Cardiovasc Disord; 2017 Dec; 17(1):289. PubMed ID: 29221440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil eliminates the hierarchical nature of activation frequencies from the pulmonary veins to the atria during paroxysmal atrial fibrillation.
    Kushiyama Y; Osaka T; Yokoyama E; Hasebe H; Kuroda Y; Kamiya K; Kodama I
    Heart Rhythm; 2010 May; 7(5):577-83. PubMed ID: 20206318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic characteristics in patients with nonrheumatic atrial fibrillation and their relation to echocardiographic parameters.
    Bollmann A; Binias KH; Sonne K; Grothues F; Esperer HD; Nikutta P; Klein HU
    Pacing Clin Electrophysiol; 2001 Oct; 24(10):1507-13. PubMed ID: 11707044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.